Show simple item record

dc.contributor.authorShiva, S
dc.contributor.authorNikzad, A
dc.contributor.authorAslanabadi, S
dc.contributor.authorMontazeri, V
dc.contributor.authorNikzad, MR
dc.date.accessioned2018-08-26T08:27:46Z
dc.date.available2018-08-26T08:27:46Z
dc.date.issued2008
dc.identifier.urihttp://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/51253
dc.description.abstractBackground: Neonatal primary hyperparathyroidism (NPHP) is a rare disease characterized by marked hypercalcemia, diffuse parathyroid hyperplasia and skeletal demineralization. These patients have symptoms of chronic hypercalcemia such as failure to thrive, irritability, abdominal pain and anorexia. It is often fatal unless parathyroidectomy is performed. Treatment with drugs usually is inadequate and often results in chronic hypercalcemia and death. Case presentation: A 10-day-old, 2.9 kg male newborn was hospitalized for anorexia, poor feeding, cyanosis, hypotonia, lethargy and severe dehydration. Diagnosis of severe hypercalcemia due to primary hyperparathyroidism was established and surgical approach selected because of failure of medical therapy to control hypercalcemia. The baby was successfully treated by total parathyroidectomy with autotransplantation. Conclusion: Although neonatal primary hyperparathyroidism (NPHP) is a rare disease, it must be considered for differential diagnosis in neonates with severe hypercalcemia. Early diagnosis and total parathyroidectomy with autotransplantation can be life-saving.
dc.language.isoEnglish
dc.relation.ispartofIRANIAN JOURNAL OF PEDIATRICS
dc.subjectprimary hyperparathyroidism
dc.subjectneonate
dc.subjectparathyroidectomy
dc.subjectautotransplantation
dc.titleSevere neonatal hypercalcemia due to primary hyperparathyroidism; A case report
dc.typeArticle
dc.citation.volume18
dc.citation.issue3
dc.citation.spage277
dc.citation.epage280
dc.citation.indexWeb of science


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record